PHAXIAM Therapeutics
A biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
Enterprise value
$15m
Share price
$0.54 ERYP
Company register number
479560013
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | €7.8m | Post IPO Equity | |
| Total Funding | 000k | ||
Eurazeo(exited)
Ardian(exited)
Auriga Partners(exited)
Auriga Partners(exited)
Rhone-Alpes Creation(exited)
Karista(exited)
Auriga Partners (Paris)(exited)
NEA(exited)
Kurma Partners(exited)
Societe Generale(exited)
Andera Partners(exited)
Pherecydes Pharma(exited)
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (25 %) | 33 % | 25 % | (20 %) | - | 675 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1132 %) | (1075 %) | (1200 %) | (1600 %) | (1275 %) | 6 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1151 %) | (950 %) | (1260 %) | (1825 %) | (1350 %) | (1 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 874 % | 898 % | 1062 % | 1494 % | 1213 % | 62 % | - |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by PHAXIAM Therapeutics
Editexited